Stay informed with the latest litigation news. Explore now

IP Verse

Genentech competitive analysis

Latest publications and patents of Genentech New

Explore the latest publications and patents granted to Genentech, showcasing their recent innovations and technological advancements.

Last updated on: Sep 9, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Genentech

EP4602606
Aug 20, 2025T Cell Quantitative Systems Pharmacology ModelPending
EP4601651
Aug 20, 2025Methods For Treating Spinal Muscular AtrophyPending
EP4595062
Aug 6, 2025Blind Denoising Of Sequencing DataPending
EP4595056
Aug 6, 2025Machine Learning Enabled Prediction Of Molecular Structures And PropertiesPending
EP4595002
Aug 6, 2025Techniques For Determining Dopaminergic Neural Cell Loss Using Machine LearningPending
EP4594320
Aug 6, 2025Hydantoin Modulators Of Cholesterol Biosynthesis And Their Use For Promoting RemyelinationPending
EP4594309
Aug 6, 2025Azole Modulators Of Cholesterol Biosynthesis And Their Use For Promoting RemyelinationPending
EP4593847
Aug 6, 2025Inhibition Of Genotoxic Stress To Improve T Cell EngineeringPending
EP4555981
Aug 6, 2025Method And Apparatus For Suprachoroidal Administration Of Therapeutic AgentPending
EP4534972
Jul 30, 2025Synthetic Controls For ImmunohistochemistryPending

Latest oppositions filed by Genentech

Explore patent oppositions filed by Genentech against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3177645
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDHOFERNov 15, 2021

Latest patents of Genentech opposed by its competitors

Explore Genentech's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2694072
Aug 7, 2024Combinations Of Akt Inhibitor Compounds And Abiraterone, And Methods Of Use1
EP4108259
Jan 3, 2024Process For Concentration Of Antibodies And Therapeutic Products Thereof1
EP3589661
Nov 1, 2023Adjuvant Treatment Of Her2-Positive Breast Cancer4
EP2784084
Oct 4, 2023Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof5
EP3597659
Mar 1, 2023Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides9
EP3805248
Jan 18, 2023Process For Concentration Of Antibodies And Therapeutic Products Thereof2
EP3401335
Jun 30, 2021Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof5
EP3337812
Apr 28, 2021Method For The Reduction Of Host Cell Proteins In Affinity Chromatography4
EP3570884
Sep 30, 2020Subcutaneous Her2 Antibody Formulations4
EP1543038
Aug 5, 2020Protein Purification1

Latest PTAB cases involving Genentech New

Discover the latest PTAB cases involving Genentech, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 15, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Genentech

IPR2023-00052Oct 14, 2022DR REDDYS LABORATORIESGENENTECHFinal Written Decision
PGR2022-00023Feb 3, 2022DR REDDYS LABORATORIESGENENTECHFinal Written Decision
PGR2021-00039Jan 20, 2021MERCK SHARP & DOHMEGENENTECHInstitution Denied
PGR2021-00036Jan 7, 2021MERCK SHARP & DOHMEGENENTECHInstitution Denied
PGR2019-00043Apr 2, 2019ELI LILLYGENENTECHTerminated
PGR2019-00044Apr 1, 2019UCBGENENTECHTerminated
IPR2018-01019May 4, 2018CELLTRIONGENENTECHTerminated
IPR2018-00373Jan 5, 2018PFIZERGENENTECHInstitution Denied
IPR2018-00330Dec 18, 2017PFIZERGENENTECHInstitution Denied
IPR2018-00331Dec 18, 2017PFIZERGENENTECHInstitution Denied

Top competitors of Genentech

Top competitors of Genentech based on patent oppositions.